The transcriptional co-activator PGC-1α is a key regulator of mitochondrial function and muscle fiber specification in the skeletal muscle. The E3 ubiquitin ligase RNF34 ubiquitinates PGC-1α and negatively regulates mammalian brown fat cell metabolism. However, the functional importance of RNF34 in the skeletal muscle and its impact on energy metabolism remain unknown. The Drosophila PGC-1 homolog dPGC-1 and its mammalian counterparts have conserved functions in mitochondria and insulin signaling. Here, we showed that the Drosophila RNF34 (dRNF34) ubiquitinates the Drosophila PGC-1α (dPGC-1) and promotes its degradation in HEK293T cells by immunoprecipitation and western blot analysis. This allows us to use Drosophila as a powerful model system to study the physiological role of RNF34 in mitochondrial function and metabolism. In the in vivo studies, by separately expressing two independent UAS-dRNF34 RNAi transgenes driven by the muscle-specific 24B-Gal4 driver, we found that knockdown of dRNF34 specifically in muscle promotes mitochondrial biogenesis, improves negative geotaxis, extends climbing time to exhaustion in moderate aged flies and counteracts high-fat-diet-induced high triglyceride content. Furthermore, we showed that knockdown of dPGC-1 reversed the effects of the dRNF34 knockdown phenotypes described above. Our results reveal that dRNF34 plays an important role in regulating mitochondrial biogenesis in muscle and lipid metabolism through dPGC-1. Thus, inhibition of RNF34 activity provides a potential novel therapeutic strategy for the treatment of agerelated muscle dysfunction.
Introduction
The transcriptional co-activator peroxisome proliferator-activated receptor γ co-activator α (PGC-1α) is a master regulator in controlling mitochondrial function and energy metabolism. Through its interaction or co-activation with other transcription factors, PGC-1α regulates mitochondrial biogenesis, respiration, and glucose homeostasis [1, 2] . In the skeletal muscle, PGC-1α is a key regulator of mitochondrial oxidative metabolism and muscle fiber specification. Moderately increased expression of PGC-1α in muscle has been shown to improve lipid utilization, insulin signaling, and glucose transport in the skeletal muscle of lean and insulin-resistant obese Zucker rats [3] . Drosophila PGC-1 homolog (dPGC-1) and its mammalian counterparts have conserved functions in respect to mitochondria and insulin signaling [4] . Studies in Drosophila have shown that dPGC-1 coordinates mitochondrial activity and is a downstream effector in the insulin-TOR signaling pathway [5, 6] , and that overexpression of dPGC-1 is associated with health benefits. For example, tissue-specific overexpression of dPGC-1 in stem and progenitor cells within the digestive tract extends life span [7] . Furthermore, muscle/heart-specific overexpression of dPGC-1 improves both negative geotaxis and cardiac performance in unexercised Drosophila [8] . RNF34 is a ubiquitously expressed E3 ubiquitin ligase which is well conserved across human, rodents, and flies. Mammalian RNF34 is a nuclear protein that interacts with and ubiquitinates PGC-1α to promote its turnover [9] . The fruit fly Drosophila melanogaster genome encodes a single homolog of the mammalian RNF34, CG17019 (hereinafter dRNF34). Sequence alignments have shown that the E3 ligase activity domain, ring finger domain, is highly conserved in dRNF34. However, the function of RNF34 in muscle in vivo has not been investigated.
In this study, we showed that dRNF34 ubiquitinates dPGC-1 and promotes its degradation in HEK293T cells, and that dRNF34 knockdown promotes mitochondrial biogenesis, improves negative geotaxis, and extends climbing time to exhaustion in fly muscle, which can be reversed by knockdown of dPGC-1. Our results revealed that dRNF34 plays an important role in regulating mitochondrial biogenesis in muscle and lipid metabolism through dPGC-1.
Materials and Methods

Plasmid construction
Two oligos (5′-AATTCGGATCCGGCGGCCGCCTCGAGGGTA CCTCTAGAC-3′ and 5′-AATTGTCTAGAGGTACCCTCGAGG CGGCCGCCGGATCCG-3′) were annealed and inserted into the EcoRI/EcoRI sites of pCR8GW TOPO vector (Invitrogen, Carlsbad, USA), resulting in a Gateway entry vector pGE1F. To generate dPGC-1 entry plasmid, dPGC-1 ORF 5′ end was amplified using PCR primers (5′-AAAAGAATTCATGGATTCACGAATG CTAA-3′ and 5′-TTCTCTTTGATAGTAGGTGTGGTC-3′) from the Drosophila dPGC-1 full-length cDNA clone FI18188 (Drosophila Genome Resource Center, DGRC, https://dgrc.bio.indiana.edu), and the PCR product was then digested with EcoRI and XmaI, resulting in a 804-bp dPGC-1 ORF 5′ end. On the other side, the dPGC-1 cDNA clone FI18188 was digested with XmaI and KpnI, resulting in a 3449-bp dPGC-1 cDNA 3′ end. The 804-bp dPGC-1 ORF 5′ end and the 3449-bp dPGC-1 cDNA 3′ end were inserted into the EcoRI/KpnI sites of pGE1F, resulting in pGE1F-dPGC-1 entry plasmid. A 3 × FLAG tag with a mammalian Kozak sequence was PCR amplified using PCR primers (5′-AAAAAAGCTTCCGCCATGG ACTACAAAGACCA-3′ and 5′-AAAATCTAGACTTGTCATCG TCATCCTT-3′) from pAFHW (Drosophila Genomics Resource Center, Bloomington, USA), and the PCR products were digested with HindIII and XbaI and inserted into the HindIII/XbaI sites of pMartini Gate A R1-R2 [10] , resulting in pMartini-h3FLAG-G. A 3 × FLAG tag and a Gateway cassette were excised from pMartini-h3FLAG-G as a HindIII/XhoI fragment and inserted into the HindIII/XhoI sites of pcDNA3.1(+), resulting in a Gateway destination vector pcDNA-3FLAG-G. The 3 × FLAG-tagged dPGC-1 construct, pcDNA-3FLAG-dPGC-1, was constructed by LR reaction between pGE1F-dPGC-1 and pcDNA-3FLAG-G using Gateway LR Clonase Enzyme Mix (Invitrogen). Five dRNF34 ORF fragments were PCR amplified from Drosophila genomic DNA and cloned into pGE1F using Gibson Assembly Master Mix (New England Biolabs, Ipswich, USA), resulting in pGE1F-dRNF34 entry plasmid. Catalytically dead Cys656Ala (C656A) mutant dRNF34 was generated by Gibson Assembly using pGE1F-dRNF34, resulting in pGE1F-dRNF34 C656A. A 3 × Myc tag with a mammalian Kozak sequence was PCR amplified using PCR primers (5′-TAAAAAG CTTCCGCCATGGAGCAGAAACTCATC-3′ and 5′-AAAATCTA GACAGATCTTCCTCAGA-3′) from pCMV-3Tag-4C (Stratagene, La Jolla, USA), and the PCR products were digested with HindIII and XbaI and inserted into the HindIII/XbaI sites of pMartini Gate A R1-R2, resulting in pMartini-h3Myc-G. A 3 × Myc tag and a Gateway cassette were excised from pMartini-h3Myc-G as a HindIII/XhoI fragment and inserted into the HindIII/XhoI sites of pcDNA3.1(+), resulting in a Gateway destination vector pcDNA3Myc-G. The 3×Myc-tagged dRNF34 construct, pcDNA-3Myc-dRNF34, was constructed by LR reaction between pGE1F-dRNF34 and pcDNA3Myc-G, resulting in pcDNA-3Myc-dRNF34. The 3 × Myc-tagged dRNF34 C656A construct, pcDNA-3Myc-dRNF34 C656A, was constructed by LR reaction between pGE1F-dRNF34 C656A and pcDNA3Myc-G. HA-tagged ubiquitin (HA-Ub) plasmid is a gift from Dr Yuzuru Imai (Juntendo University, Tokyo, Japan).
Fly stocks, diet, and husbandry
The fly lines w 1118 , UAS-dPGC-1 RNAi (BDSC#33914) and 24B-Gal4 were purchased from the Bloomington Drosophila Stock Center (BDSC, Bloomington, USA). The fly lines UAS-dRNF34 RNAi (VDRC#48749) and UAS-dRNF34 RNAi (VDRC#48748) were obtained from the Vienna Drosophila Resource Center (VDRC, Vienna, Austria). 24B-Gal4/+ flies (F1 progenies from the cross of w 1118 and 24B-Gal4) were used as the RNF34 RNAi control. The UAS RNAi sequences are shown in the Supplementary Data. Normal diet contains 2.1% yeast, 13.7% brown sugar, 8% corn powder, and 0.65% agar. During the experimental time course, flies were housed in a 25°C incubator with 50% humidity and a 12-h light/dark cycle. Fresh food was provided every 2 days for the duration of the experiment. High-fat diet contains 30% coconut oil plus normal food [11, 12] .
Triglyceride assay
Triglyceride (TAG) was measured as described previously [13] . Briefly, for each sample, five adult flies with heads removed or the thorax or abdomen body parts of an appropriate genotype were rinsed with ice-cold PBS and then homogenized on ice in an Eppendorf tube with 50-100 μl of cold PBS with 0.05% Tween 20 (PBST). A total of 10 μl homogenized sample was used to measure protein content using a Bradford assay kit (Solarbio, Beijing, China). Supernatant was heated for 10 min at 70°C. Aliquots of 2 μl of supernatant were transferred to a 96-well plate and measured using the Serum Triglyceride Determination Kit (Sigma, St Louis, USA). The TAG content was calculated from a standard curve constructed with TAG solutions of known concentrations according to the manufacturer's instruction. Samples were analyzed in triplicate. Protein content was used for normalization.
Quantitative real-time PCR (qPCR) analysis
Total RNA was extracted using Trizol reagent (Invitrogen). Reverse transcription (RT) was performed using a Reverse Transcription Kit (Takara, Shiga, Japan) according to the manufacturer's instruction. Total RNA (500 ng) was used as the template. The RT product was diluted by 1:20 with water and an aliquot of 2 μl was applied to qPCR amplification reactions (a pre-incubation at 95°C for 10 min followed by 95°C 15 s and 60°C 30 s for 40 cycles) using LightCycler FastStart DNA Master SYBR Green I (Roche, Basel, Switzerland). Primer sequences used are listed below: Drosophila Act5C: 5′-TTGTCTGGGCAAGAGGATCAG-3′ (F) and 5′-ACCACTCGCAC TTGCACTTTC-3′ (R) (internal control); dPGC-1: 5′-GGATTCA CGAATGCTAAATGTGTTCC-3′ (F) and 5′-ATGGGTAGGA TGCCGCTCAG-3′ (R) [7] ; and dRNF34: 5′-GCGAGTGTCCAGC TGTTGAA-3′ (F) and 5′-TGGGCACTCGTTCAACACTT-3′ (R).
Mitochondrial DNA measurement
Mitochondrial DNA was measured as described previously [7] . Briefly, five thoraxes were homogenized in buffer containing 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.1% Triton X-100 and 10 μg/ml protease K, then incubated at 37°C for 60 min, 95°C for 5 min to inactivate protease K. The DNA product was diluted by 1:20 with water. Mitochondrial DNA was quantified relative to nuclear DNA by the ratio of amplicons of cytochrome oxidase subunit I (COI) to amplicons of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in qPCR. Primer sequences used are listed below: Drosophila COI (mitochondrial DNA): 5′-GAATTAGGACATCCTGGAGC-3′ (F) and 5′-GCACTAATCAATTTCCAAATCC-3′ (R); Drosophila GAPDH (internal control for mitochondrial DNA): 5′-GACGAAAT CAAGGCTAAGGTCG-3′ (F) and 5′-AATGGGTGTCGCTGAAG AAGTC-3′ (R).
Ubiquitination assay and co-immunoprecipitation
The in vivo ubiquitination assay was performed as described previously [9] . Briefly, HEK293T cells were plated 1 × 10 6 cells/well in 6-well plate.
And 24 h later HEK293T cells were transfected with 100 μl transfection complex containing 1 μg of each of the plasmids as indicated, 5 μl of Hieff Trans TM Liposomal Transfection Reagent (Yeasen, Shanghai, China) in serum-free medium without penicillin/streptomycin. Cells were cultured for another 24 h and then treated with proteasome inhibitor MG132 (10 μM Sigma) for 6 h prior to lysis. Cells were lysed in buffer A (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.5% Triton X-100, and 5% glycerol) containing 10 μM MG132. Cell extracts were incubated with anti-FLAG antibody-conjugated beads (Sigma) at 4°C for 2 h. The beads were washed four times with buffer B (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.1% Triton X-100, and 5% glycerol) containing 10 μM MG132. Immunoprecipitates or protein extracts were subject to western blot analysis.
Western blot analysis
Western blot analysis was performed using standard protocols. Protein samples were separated by 8% SDS-PAGE and transferred to nitrocellulose membranes. Primary antibodies used in this study are rabbit anti-FLAG antibody (1:1000; Sigma), rabbit anti-Myc tag antibody (1:1000; Cell Signaling, Danvers, USA), rabbit anti-HA antibody (1:1000; Sigma) and mouse anti-β-tubulin antibody (1:1000; Developmental Studies Hybridoma Bank, Iowa City, USA).
Citrate synthase activity assay
Citrate synthase activity assay was carried out as previously described [7] . Ten thoraxes of adult flies were lysed in 500 μl of extraction buffer containing 20 mM HEPES, pH 7.2, 1 mM EDTA, and 0.1% Triton X-100. Citrate synthase activity was measured using 1 μl of cell lysate in a total of 150 μl of reaction buffer containing 50 mM Tris-HCl, pH 8.0, 0.1 mM dithio-bis-nitrobenzoic acid (DTNB) (Sigma), 0.3 mM acetyl-CoA (Sigma) and 1 mM oxaloacetate (Sigma). Absorbance was measured at 412 nm every 30 s for 5 min at 25°C using an Eon Microplate Spectrophotometer (BioTek, Winooski, USA). Citrate synthase activity was normalized by protein concentrations.
Transmission electron microscopy
Samples were fixed with 2% glutaraldehyde in PBS (pH 7.2) at 4°C for 2 h, washed, and then post-fixed in 1% osmium tetroxide at 4°C for 2 h. After being washed twice, the fixed samples were dehydrated through a graded series of ethanol to 100%, and then rinsed twice with propylene oxide and once with a 1:1 (v/v) mixture of propylene oxide:epoxy resin (618) (Ted Pella, Redding, USA) for 2 h. Finally, samples were rinsed once with a 1:2 (v/v) mixture of propylene oxide: epoxy resin (618), and left overnight to infiltrate. Samples were processed through a fresh epoxy resin and embedded at 37°C for 6 h, and the blocks were allowed to polymerize for 48 h at 60°C. Ultrathin sections were cut on an LKB-V Ultramicrotome (LKB, Bromma, Sweden) using a diamond knife. The sections (64-nm thick) were collected and mounted on copper support grids and contrasted with lead citrate and uranyl acetate, and examined on a Philips CM-120 Transmission Electron Microscope (Philips Lighting Innovation Labs, Eindhoven, The Netherlands) at 80 kV accelerating voltage. Mitochondrial density was calculated by counting the mitochondria number on five 5800 × individual micrographs for each genotype.
Negative geotaxis climbing assay
Negative geotaxis climbing assay was performed in male flies at the indicated days after eclosion [8, 14] . Briefly, more than 60 flies for each genotype were collected and age-matched within 1-2 days of each other. For the analysis of climbing speed, 20 flies of the same group were placed in a 100-ml clear glass cylinder, and the cylinder was then plugged with a soft sponge stopper. All flies were manually tapped down to the bottom of a vial. Due to an innate escape response, flies ascended the wall of the cylinder. The climbing behavior was recorded by a digital video camera (Canon, Tokyo, Japan). The procedure was repeated until all the flies were assayed. Climbing speed was recorded as the height that an individual fly climbed on the wall of the cylinder within 8 s. The results were expressed as a climbing index, which is a ratio of the average climbing speed of a group to that of the control group.
Exhaustion assay
The male flies were exercised on a Power Tower machine, which is a custom-made electric seesaw as described previously [15] , at the indicated days after eclosion. For the analysis of exhaustion time, more than 60 flies for each genotype were collected and agematched within 1-2 days of each other. Twenty flies of the same group were placed in a plastic vial containing fresh food. The vials were tied on the plate of the Power Tower Machine. The Power Tower Machine was turned on and the power was adjusted to that the period between drops was 5 s. All flies were continuously tapped down to the bottom of the vials by the Power Tower Machine. Due to an innate escape response, flies ascended the wall of the tubes over an extended period of time. Flies were considered 'exhausted' and the time was recorded once 90% of the flies in a vial remained on the bottom of the vial [8] .
Statistical analysis
The two-tailed Student's t-test was used for statistical analysis. Data are presented as the mean ± standard errors of the means. A P value <0.05 was considered to be of statistical significance.
Results
dRNF34 ubiquitinates dPGC-1 and promotes its degradation
To examine whether dRNF34 ubiquitinates dPGC-1, HEK293T cells were transfected with Flag-tagged dPGC-1, Myc-tagged wild-type dRNF34 or catalytically dead C656A mutant dRNF34, and HAubiquitin in the presence of the proteasome inhibitor MG132. FlagdPGC-1 proteins were then immunoprecipitated with anti-Flag beads. Subsequent immunoblotting with anti-HA revealed that wild-type dRNF34, but not dRNF34 C656A, strongly increased the level of ubiquitinated dPGC-1 proteins (Fig. 1A) , even though both the input and the immunoprecipitated dPGC-1 levels were less than other lanes when co-expressed with dRNF34. These results suggest that dRNF34 is an E3 ubiquitin ligase for dPGC-1. Next, we examined whether dRNF34 promotes dPGC-1 degradation by western blot analysis. HEK293T cells were co-transfected with Flag-dPGC-1 and Myc-dRNF34 or Myc-dRNF34 C656A. It was found that expression of dRNF34 decreased the dPGC-1 protein level significantly, whereas the C656A mutant had little effect (Fig. 1B) . To detect the interaction between dRNF34 and dPGC-1, we expressed Flag-dPGC-1 along with MycdRNF34 or Myc-dRNF34 C656A. Co-immunoprecipitation and western blot analysis results showed that dPGC-1 interacted with both dRNF34 and the C656A mutant (Fig. 1C) . These results indicate that dRNF34 is an E3 ubiquitin ligase for dPGC-1.
Flag-dPGC-1 HA-Ub Increased mitochondrial density and activity caused by muscle-specific dRNF34 knockdown were reversed by dPGC-1 knockdown in Drosophila (A) Both of the dRNF34 RNAi lines cause about 60% reduction in dRNF34 mRNA levels. Data were presented as the mean ± SEM (n = 3). **P < 0.01. (B) Knockdown of Drosophila dRNF34 in muscle increased mtDNA content as determined by qPCR in adult male thoraxes compared with the control. Data were presented as the mean ± SEM (n = 3). *P < 0.05. This effect was reversed by knockdown of dPGC-1. mtDNA units are relative to the amounts of an nuclear DNA (nDNA) amplicon (n = 3, 5 thoraxes per replicate). (C) Mitochondrial density (5800×, n = 5 per genotype). Examination of mitochondrial density by transmission electron microscopy showed an increase of mitochondrial densities in the indirect flight muscles of the two strains with dRNF34 knockdown. This effect was reversed by knockdown of dPGC-1. All assays in adults were carried out at Day 10 after eclosion. Arrows indicate mitochondria. (D) Quantitative analysis of mitochondrial density examined by transmission electron microscopy. Data were presented as the mean ± SEM (n = 5). *P < 0.05. (E) Thoraxes of male flies with knockdown of dRNF34 showed an increase in citrate synthase activity, which was reversed by knockdown of dPGC-1. Data were presented as the mean ± SEM (n = 3, 10 thoraxes per replicate). *P < 0.05. dRNF34 RNAi(II): UAS-dRNF34 RNAi (VDRC#48749); dRNF34 RNAi(III): UAS-dRNF34 RNAi (VDRC#48748).
Knockdown of dRNF34 in Drosophila muscle induces mitochondrial biogenesis
To investigate the function of dRNF34 in muscle in vivo, we separately expressed two independent transgenic UAS-dRNF34 RNAi constructs in all developing muscles with the muscle-specific 24B-Gal4 driver [16] . It was found that both of the dRNF34 RNAi lines caused about 60% reduction in the dRNF34 mRNA level (Fig. 2A) . We next tested whether knockdown of dRNF34 in Drosophila muscle in vivo has any effects on mitochondrial biogenesis, as a recent report has shown that knockdown of RNF34 in mammalian brown fat cells increases mitochondrial abundance and activity [9] . Thoraxes are muscle-rich tissues and were therefore used for the measurement of changes in mitochondrial abundance in adult flies. We first measured the mitochondrial DNA (mtDNA) content relative to that of a nuclear DNA (nDNA) amplicon. An almost 2-fold increase of the mtDNA content was observed in adult thoraxes in response to dRNF34 knockdown mediated by either of the two transgenic UAS-dRNF34 RNAi constructs (Fig. 2B) . Moreover, knockdown of dRNF34 leads to increased mitochondrial densities in the indirect flight muscles of adult flies, as revealed by transmission electron microscopy ( Fig. 2C,  D) . Consistent with these findings, citrate synthase activity in adult thoraxes was significantly increased in either of the two dRNF34 knockdown lines (Fig. 2E) . Similar results were observed using two independent dRNF34 RNAi lines, which suggested that these results may not be caused by off-target effects of dRNF34 RNAi. Together, these data suggest that knockdown of dRNF34 in muscle in vivo promotes muscle mitochondrial biogenesis.
Knockdown of dRNF34 in muscle improves negative geotaxis and extends climbing time to exhaustion in moderately aged flies To test whether the E3 ubiquitin ligase dRNF34 affects muscle performance during aging, we measured the negative geotaxis in male flies of different age in the unexercised condition. It was found that the climbing speeds of flies of all the genotypes progressively declined with age (Fig. 3A) . Interestingly, the climbing speed of control flies declined rapidly until Day 20 after eclosion, but declined slowly from Day 21 to 30 after eclosion (Fig. 3A) , which is consistent with previous reports [17, 18] . At Day 20 after eclosion, the climbing speeds of the two dRNF34 RNAi knockdown groups were significantly higher than that of the control, whereas at Day 5 or Day 30 after eclosion, there is no significant difference compared with the control (Fig. 3A) . We conclude that muscle-specific knockdown of dRNF34 improves negative geotaxis in moderately aged flies.
Next, we measured the effects of muscle-specific dRNF34 knockdown on climbing time to exhaustion of flies, as climbing time to exhaustion is commonly used as a parameter of endurance. Climbing of flies was continuously induced on a Power Tower Machine over an extended period of time, and then we measured the time at which 90% of flies stopped climbing entirely while undergoing continuous induction of climbing. dRNF34 knockdown in muscle was found to result in significantly increased climbing time to exhaustion in adult flies (Day 8) (Fig. 3B) . This result suggests that dRNF34 knockdown in muscle improves muscular endurance in adult flies. 
Knockdown of dRNF34 in muscle ameliorates lipid metabolism in Drosophila
Since dRNF34 modulates mitochondrial biogenesis in Drosophila muscle (Fig. 2) and mitochondrial function modulates fatty acid metabolism [19, 20] , we next tested whether knockdown of dRNF34 in muscle affects lipid metabolism in Drosophila. The TAG and glucose levels were examined in flies with muscle-specific dRNF34 knockdown. Newly hatched flies were raised on normal diet (ND) for 5 days and then transferred to high-fat diet (HFD) for another 5 days. It was found that muscle-specific dRNF34 knockdown reduced the HFD-induced high TAG level in abdomens (Fig. 4A) , but did not affect the TAG level in thoraxes or the body glucose level under HFD (data not shown); whereas under ND, it had no effects on body weight, food intake, body TAG or glucose levels (data not shown).
Thus, these data suggest that knockdown of dRNF34 in muscle counteracts the HFD-induced high TAG level in abdomens.
Next, we tested whether knockdown of dRNF34 in muscle has any effects on insulin gene expression in Drosophila. A total of seven Drosophila insulin-like peptide (Dilp) genes are found in the Drosophila genome. Three distinct Dilp genes, Dilp2, Dilp3, and Dilp5, are expressed in the insulin-producing cells (IPCs) in the Drosophila brain. Studies have defined that Dilp2 plays a role in carbohydrate metabolism and Dilp3 has been implicated to modulate lipid metabolism, whereas a metabolic role for Dilp5 is yet to be determined [21] . qPCR analysis showed that only Dilp3 transcript was decreased significantly in the brain of adult flies with musclespecific dRNF34 knockdown on ND, whereas the levels of Dilp2 and Dilp5 were not affected compared with the control (Fig. 4B) . These data are consistent with our finding that dRNF34 plays a role in lipid metabolism. Relative mRNA expression Relative mRNA expression Relative mRNA expression * * Figure 4 . Ameliorated lipid metabolism caused by muscle-specific dRNF34 knockdown was reversed by dPGC-1 knockdown in Drosophila Triglyceride (TAG) content in abdomen was determined by coupled colorimetric assay and was then normalized by protein level. Data were presented as the mean ± SEM (n = 3, 10 flies per replicate). *P < 0.05. (B) The mRNA level of Dilp2, Dilp3 and Dilp5 in brain was determined by qPCR analysis. All assays in adult fly heads were carried out at Day 10 after eclosion. Data were presented as the mean ± SEM (n = 3, 10 flies per replicate). *P < 0.05. dRNF34 RNAi(II): UAS-dRNF34 RNAi (VDRC#48749); dRNF34 RNAi(III): UAS-dRNF34 RNAi (VDRC#48748).
Muscle-specific knockdown of dPGC-1 reverses the effects of muscle-specific knockdown of dRNF34 in Drosophila
To investigate whether the effects of muscle-specific knockdown of dRNF34 are mediated through dPGC-1, we knocked down both dPGC-1 and dRNF34 simultaneously using a muscle-specific 24B-Gal4 driver. RT-qPCR experiments indicated that the dPGC-1 RNAi line caused an 80% reduction in muscle dPGC-1 mRNA level (data not shown). As expected, RNAi knockdown of dPGC-1 in muscle reversed the effect of dRNF34 knockdown on mitochondria biogenesis (Fig. 2) . Similarly, the effects on climbing speed, climbing time to exhaustion and lipid metabolism caused by muscle-specific dRNF34 knockdown were all reversed by muscle-specific knockdown of dPGC-1 (Figs. 3 and 4) . Taken together, these results indicate that the effects of muscle-specific dRNF34 knockdown are mediated through dPGC-1.
Discussion
Drosophila is an excellent model for the study of metabolism and aging-related disease. Many molecules and pathways that play pivotal roles in metabolism and aging-related disease are highly conserved across human and Drosophila [4, 6, 22] . In this study, we found that the Drosophila RNF34 (dRNF34) ubiquitinates the Drosophila PGC-1α (dPGC-1) and promotes its degradation. Furthermore, using Drosophila as a model, we discovered that dRNF34 plays an important role in regulating mitochondrial biogenesis in muscle and lipid metabolism through dPGC-1. Aging causes a gradual loss of skeletal muscle mass and function, which is a condition known as sarcopenia [23] . Sarcopenia is a world-wide public health concern, as it affects physical activity and life quality in the entire aging population [24] . The mechanisms underlying sarcopenia remain largely unknown, but mitochondrial dysfunction has been strongly implicated in the onset of sarcopenia [25] . Mitochondrial dysfunctions were observed in aged muscle in human, mice, and Drosophila [26] . PGC-1α increases mitochondrial biogenesis and compensates for mitochondrial dysfunction [27, 28] . Hence, stimulation of PGC-1α activity may be an effective strategy to treat sarcopenia. Intriguingly, we observed that muscle-specific RNAi knockdown of dRNF34 counteracted the HFD-induced high TAG level in Drosophila abdomens, but not in the muscle-rich tissue, thorax. The Drosophila abdomen is enriched in fat body that is equivalent of mammalian liver and adipose tissue. A possible explanation for this observation could be due to the cross talk between muscle and fat body [29, 30] , but might not be caused by leaky expression of muscle-specific 24B-Gal4 in other tissues, as 24B-Gal4 has no leaky expression in fat body [31] . Given the important role of dRNF34 in modulating mitochondrial biogenesis through dPGC-1 in Drosophila muscle, inhibition of human RNF34 activity may provide a novel therapeutic strategy for the treatment of age-related muscle dysfunction such as sarcopenia and lipid metabolism disorder.
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